Crossmark

Evaluation of PD-L1, TERT promoter mutations, and BRAFV600E mutation in poorly differentiated, differentiated high grade thyroid carcinoma and anaplastic carcinoma of the thyroid: our institutional experience

Crossref DOI link: https://doi.org/10.1007/s00428-025-04134-1

Published Online: 2025-06-07

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Piermattei, Alessia

Migliara, Giuseppe

Feraco, Angela

Bruno, Carmine

Cioni, Luisa

Zhang, Qianqian

Padial-Urtueta, Belen

Merenda, Elisabetta

Fadda, Guido

Raffaelli, Marco

Larocca, Luigi Maria

Mule, Antonino

Pontecorvi, Alfredo

Rossi, Esther Diana https://orcid.org/0000-0003-3819-4229
License Information

Text and Data Mining valid from 2025-06-07

Version of Record valid from 2025-06-07
More Information

Article History

Received: 15 April 2025

Revised: 21 May 2025

Accepted: 23 May 2025

First Online: 7 June 2025

Declarations

:

: Ethical approval from the internal Committee Policlinico Gemelli 2023 n* 123.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below